A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Condition: Hepatitis CInterventions: Drug: Telaprevir; Drug: Ribavirin; Biological: Pegylated Interferon Alfa-2a; Drug: Highly Active Antiretroviral Therapy (HAART)Sponsor: Vertex Pharmaceuticals IncorporatedTerminated - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hepatitis | Hepatitis C | Highly Active Antiretroviral Therapy | Incivek | Research | Study